Samir Patel
Equibles does not estimate personal net worth.
Get an email with a short summary when Akari Therapeutics Plc publishes a filing, an earnings call transcript or a press release.
Get AKTX alertsAbout Samir Patel
Samir Patel is recorded as CFO at Akari Therapeutics Plc (AKTX) since December 12, 2024. Akari Therapeutics Plc reported in an 8-K filed December 12, 2024 that Samir Patel was appointed Interim Principal Financial Officer and Principal Accounting Officer, effective December 12, 2024. Akari Therapeutics Plc is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Akari Therapeutics Plc includes Abizer Gaslightwala (CEO and Board Member), Samir R. Patel (CEO), Samir R. Patel, M.D. (CEO) and 6 others.
“On December 12, 2024, the board of directors of the Company (the “Board”) approved the appointment of Samir Patel, the Company’s interim Chief Executive Officer and a member of the Company’s Board, to Interim Principal Financial Officer and Principal Accounting Officer, effective December 12, 2024, to serve in such capacities until such time as a new Chief Financial Officer commences employment or such other date determined by the Board.”
Affiliation history
-
Current
2024-12-12–present
Company network
Leadership on record at Akari Therapeutics Plc
- Abizer Gaslightwala CEO, Board Member
- Samir R. Patel CEO
- Samir R. Patel, M.D. CEO
- Hoyoung Huh Chairman, Board Member
- Kameel Farag CFO
- Torsten Hombeck CFO
- James Neal Board Member
- Robert Bazemore Board Member
- Sandip Patel Board Member